Trial · NCT01552902
Results by group21
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 21
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 6 | Placebo | -17 | Standard Error 1.03 | units on a scale | |
| Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 6 | Lisdexamfetamine Dimesylate | -25.4 | Standard Error 0.74 | units on a scale | |
| Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 6 | Methylphenidate | -22.1 | Standard Error 0.73 | units on a scale | |
| Percentage of Participants With an Improvement on Clinical Global Impression - Global Improvement (CGI-I) at Week 6 | Placebo | 50 | percentage of participants | ||
| Percentage of Participants With an Improvement on Clinical Global Impression - Global Improvement (CGI-I) at Week 6 | Lisdexamfetamine Dimesylate | 81.4 | percentage of participants | ||
| Percentage of Participants With an Improvement on Clinical Global Impression - Global Improvement (CGI-I) at Week 6 | Methylphenidate | 71.3 | percentage of participants | ||
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs | Placebo | Participants with TEAEs | 49 | participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs | Lisdexamfetamine Dimesylate | Participants with TEAEs | 145 | participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs | Methylphenidate | Participants with TEAEs | 129 | participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs | Placebo | Participants with serious TEAEs | 1 | participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs | Lisdexamfetamine Dimesylate | Participants with serious TEAEs | 1 | participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs | Methylphenidate | Participants with serious TEAEs | 1 | participants | |
| Change From Baseline in Blood Pressure at Week 6 | Placebo | Systolic blood pressure | -1 | Standard Deviation 9.88 | millimeter of mercury (mmHg) |
| Change From Baseline in Blood Pressure at Week 6 | Lisdexamfetamine Dimesylate | Systolic blood pressure | 1.5 | Standard Deviation 9.56 | millimeter of mercury (mmHg) |
| Change From Baseline in Blood Pressure at Week 6 | Methylphenidate | Systolic blood pressure | 2.4 | Standard Deviation 9.97 | millimeter of mercury (mmHg) |
| Change From Baseline in Blood Pressure at Week 6 | Placebo | Diastolic blood pressure | -0.1 | Standard Deviation 8.1 | millimeter of mercury (mmHg) |
| Change From Baseline in Blood Pressure at Week 6 | Lisdexamfetamine Dimesylate | Diastolic blood pressure | 3.4 | Standard Deviation 8.15 | millimeter of mercury (mmHg) |
| Change From Baseline in Blood Pressure at Week 6 | Methylphenidate | Diastolic blood pressure | 3.5 | Standard Deviation 8.59 | millimeter of mercury (mmHg) |
| Change From Baseline in Pulse Rate at Week 6 | Placebo | 2.4 | Standard Deviation 10.81 | Beats per minute | |
| Change From Baseline in Pulse Rate at Week 6 | Lisdexamfetamine Dimesylate | 6.7 | Standard Deviation 12.46 | Beats per minute |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01552902/results